The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCRH Regulatory News (CRH)

Share Price Information for CRH (CRH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 6,412.00
Bid: 6,422.00
Ask: 6,428.00
Change: 152.00 (2.43%)
Spread: 6.00 (0.093%)
Open: 6,380.00
High: 6,442.00
Low: 6,284.00
Prev. Close: 6,260.00
CRH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

CRH agrees $2.1bn acquisition in Texas

21 Nov 2023 07:00

RNS Number : 0580U
CRH PLC
21 November 2023
 

Press Release

CRH agrees $2.1bn acquisition of materials assets in Texas

 

 

CRH plc, the leading provider of building materials solutions, is pleased to announce that it has reached an agreement to acquire an attractive portfolio of cement and readymixed concrete assets in Texas, USA (the "Assets") from Martin Marietta Materials, Inc. for a total consideration of $2.1 billion. The combined portfolio of assets is expected to generate pro-forma 2023 EBITDA of approximately $170 million.

 

The Assets comprise a 2.1mt capacity cement plant located between San Antonio and Austin, a network of terminals along the eastern gulf coast of Texas and a portfolio of 20 readymixed concrete plants with annual shipments of c.1.6m cubic yards serving the Austin and San Antonio markets.

 

Albert Manifold, Chief Executive of CRH, said: "The acquisition of these high-quality assets further strengthens our market leading position in Texas and increases our exposure to attractive, high-growth markets. Our ability to leverage our cement expertise and technical capabilities will enable us to enhance and optimize our existing footprint in Texas, resulting in significant synergies and self-supply opportunities. This transaction reflects our disciplined approach to capital allocation as well as our commitment to deliver further growth and value creation for our shareholders. We also believe there is significant potential to unlock additional growth opportunities across an expanded footprint in this attractive growth market".

 

The proposed transaction is subject to regulatory approval and is expected to complete in H1 2024.

 

****

 

Contact CRH at Dublin 404 1000 (+353 1 404 1000)

Albert Manifold

Chief Executive

Jim Mintern

Chief Financial Officer

Frank Heisterkamp

Director of Capital Markets & ESG

Tom Holmes

Head of Investor Relations

 

 

About CRH

CRH (NYSE: CRH, LSE: CRH) is the leading provider of building materials solutions that build, connect and improve our world. Employing c.75,800 people at c.3,160 operating locations in 29 countries, CRH has market leadership positions in both North America and Europe. As the essential partner for road and critical utility infrastructure, commercial building projects and outdoor living solutions, CRH's unique offering of materials, products and value-added services helps to deliver a more resilient and sustainable built environment. The company is ranked among sector leaders by Environmental, Social and Governance (ESG) rating agencies. A Fortune 500 company, CRH's shares are listed on the NYSE and LSE.

 

Registered Office: No 12965. Registered Office: 42 Fitzwilliam Square, Dublin 2, R02 R279, Ireland

 

Forward-Looking Statements

 

This document contains statements that are, or may be deemed to be forward-looking statements within the meaning of the United States Private Securities Litigation Reform Act of 1995.

 

These forward-looking statements may generally, but not always, be identified by the use of words such as "will", "believe", "continues", "is expected to", or similar expressions. These forward-looking statements include all matters that are not historical facts or matters of fact at the date of this document.

 

This document contains statements that are, or may be deemed to be, forward-looking statements with respect to the financial condition, results of operations, business, viability and future performance of CRH and certain of the plans and objectives of CRH, including but not limited to statements regarding expectations for the anticipated proforma EBITDA of combined assets; plans and expectations for CRH's operations and market position in Texas; and plans and expectations related to the anticipated benefits and timing of the transaction.

 

Forward-looking statements are subject to risks, uncertainties and other factors because they relate to events and depend on circumstances that may or may not occur in the future and/or are beyond CRH's control or precise estimate.

 

Such risks, uncertainties and other factors include, but are not limited to, economic and financial conditions, including market turbulence, high interest rates, inflation, price volatility and/or labour and materials shortages in various countries and regions where we operate; the pace of growth in the sectors in which we operate; demand for infrastructure, residential and non-residential construction and our products in our geographic markets; increased competition and its impact on prices; and increases in energy and/or raw materials costs. There are other important factors, risks and uncertainties that could cause actual outcomes and results to be materially different, including risks and uncertainties relating to CRH described under "Principal Risks and Uncertainties" in CRH's Report on Form 6-K regarding the results for the six-month period ended 30 June 2023, as filed with the US Securities and Exchange Commission (the "SEC"), as well as "Principal Risks and Uncertainties (Risk Factors)" in the Company's 2022 Annual Report on Form 20-F as filed with the SEC.

 

You are cautioned not to place undue reliance on any forward-looking statements. These forward-looking statements are made as of the date of this document. The Group expressly disclaims any obligation or undertaking to publicly update or revise these forward-looking statements other than as required by applicable law.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ACQLBLLLXFLXFBE
Date   Source Headline
3rd May 20249:45 amRNSTransaction in Own Shares
3rd May 20249:30 amRNSTransaction in Own Shares
2nd May 20249:00 amRNSTransaction in Own Shares
1st May 20249:00 amRNSTransaction in Own Shares
30th Apr 20244:00 pmRNSTotal Voting Rights
30th Apr 20249:30 amRNSTransaction in Own Shares
29th Apr 20249:30 amRNSTransaction in Own Shares
25th Apr 20245:00 pmRNSDirector/PDMR Shareholding
25th Apr 20244:30 pmRNSAGM Statement
25th Apr 20248:30 amRNSTransaction in Own Shares
4th Apr 20244:15 pmRNSTransaction in Own Shares
2nd Apr 20244:10 pmRNSBlock listing Interim Review
2nd Apr 20243:08 pmRNSTotal Voting Rights
27th Mar 20245:30 pmRNSDirector/PDMR Shareholding
22nd Mar 20244:30 pmRNSDirector/PDMR Shareholding
20th Mar 20249:30 amRNSTransaction in Own Shares
19th Mar 20249:40 amRNSTransaction in Own Shares
19th Mar 20249:15 amRNSTransaction in Own Shares
15th Mar 20243:15 pmRNSNotice of AGM
15th Mar 20249:30 amRNSTransaction in Own Shares
14th Mar 20249:30 amRNSTransaction in Own Shares
13th Mar 20249:30 amRNSTransaction in Own Shares
12th Mar 20249:15 amRNSTransaction in Own Shares
11th Mar 20249:30 amRNSTransaction in Own Shares
8th Mar 20245:00 pmRNSDirector/PDMR Shareholding
8th Mar 20249:30 amRNSTransaction in Own Shares
7th Mar 20249:30 amRNSTransaction in Own Shares
6th Mar 20248:45 amRNSTransaction in Own Shares
5th Mar 20245:30 pmRNSDirector/PDMR Shareholding
5th Mar 20249:45 amRNSTransaction in Own Shares
4th Mar 20244:00 pmRNSTransaction in Own Shares
4th Mar 20249:45 amRNSTransaction in Own Shares
1st Mar 20243:00 pmRNSTransaction in Own Shares
29th Feb 20243:00 pmRNSTotal Voting Rights
29th Feb 202412:05 pmRNS2023 Annual Report on Form 10-K
29th Feb 20248:45 amRNSTransaction in Own Shares
28th Feb 20249:30 amRNSTransaction in Own Shares
27th Feb 20249:30 amRNSTransaction in Own Shares
26th Feb 20249:30 amRNSTransaction in Own Shares
23rd Feb 20249:30 amRNSTransaction in Own Shares
23rd Feb 20247:05 amRNS5% Preference Shares - Listings Update
22nd Feb 20249:30 amRNSTransaction in Own Shares
21st Feb 20249:30 amRNSTransaction in Own Shares
21st Feb 20247:05 amRNS5% Preference Shares - Listings Update
19th Feb 20249:30 amRNSTransaction in Own Shares
16th Feb 20249:30 amRNSTransaction in Own Shares
15th Feb 20249:30 amRNSTransaction in Own Shares
14th Feb 20249:30 amRNSTransaction in Own Shares
9th Feb 20249:30 amRNSTransaction in Own Shares
8th Feb 20249:30 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.